Clinical Trial Update: Efficacy of Rifaximin in Patients With Small Intestinal Bacterial Overgrowth Presenting With Abdominal Bloating. [NA]

View source ↗

Summary

A clinical trial evaluating rifaximin for abdominal bloating in small intestinal bacterial overgrowth is currently recruiting (NCT06772064).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Small Intestinal Bacterial Overgrowth

Drugs mentioned

• Rifaximin (rifaximin)

Snippet

Sponsor: Xiuli Zuo | Conditions: SIBO | NA | Status: RECRUITING